We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+4.45%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$24.5B
AUM Growth
-$766M
(-3%)
Cap. Flow
+$1.16B
Cap. Flow
% of AUM
4.71%
Top 10 Holdings %
Top 10 Hldgs %
14.99%
Holding
4,039
New
907
Increased
1,143
Reduced
1,068
Closed
874
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$208M |
| 2 |
CVS Health
CVS
|
+$132M |
| 3 |
Comcast
CMCSA
|
+$114M |
| 4 |
Honeywell
HON
|
+$94.8M |
| 5 |
ConocoPhillips
COP
|
+$92.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$233M |
| 2 |
iShares China Large-Cap ETF
FXI
|
+$228M |
| 3 |
Apple
AAPL
|
+$195M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$157M |
| 5 |
Nike
NKE
|
+$132M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.7% |
| 2 | Consumer Discretionary | 10.58% |
| 3 | Healthcare | 6.83% |
| 4 | Industrials | 5.75% |
| 5 | Financials | 5.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2851
Tarsus Pharmaceuticals
TARS
$2.56B
| $175K | ﹤0.01% |
+13,937
| New | +$204K |
|
|
BRY
2852
DELISTED
Berry Corp
BRY
| $174K | ﹤0.01% |
22,192
+11,628
| +110% | +$101K |
|
|
GORV
2853
DELISTED
Lazydays
GORV
| $174K | ﹤0.01% |
+497
| New | +$187K |
|
2854
Constellium
CSTM
$3.96B
| $172K | ﹤0.01% |
11,245
-64,730
| -85% | -$942K |
|
|
DVAX
2855
DELISTED
Dynavax Technologies
DVAX
| $171K | ﹤0.01% |
17,450
-14,832
| -46% | -$158K |
|
|
ARC
2856
DELISTED
ARC Document Solutions, Inc.
ARC
| $171K | ﹤0.01% |
+53,937
| New | +$180K |
|
2857
Fennec Pharmaceuticals
FENC
$347M
| $170K | ﹤0.01% |
+20,393
| New | +$189K |
|
|
LUNA
2858
DELISTED
Luna Innovations Incorporated
LUNA
| $169K | ﹤0.01% |
+23,505
| New | +$208K |
|
2859
TH International
THCH
$52.9M
| $168K | ﹤0.01% |
+8,246
| New | +$166K |
|
|
DDL
2860
Dingdong
DDL
$529M
| $166K | ﹤0.01% |
+43,054
| New | +$208K |
|
|
ADAM
2861
Adamas Trust
ADAM
$777M
| $165K | ﹤0.01% |
16,605
+5,157
| +45% | +$55.9K |
|
2862
Fulton Financial
FULT
$4.7B
| $165K | ﹤0.01% |
11,937
-32,862
| -73% | -$532K |
|
|
GRTS
2863
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $165K | ﹤0.01% |
+59,308
| New | +$169K |
|
|
NXDT
2864
NexPoint Diversified Real Estate Trust
NXDT
$281M
| $165K | ﹤0.01% |
+15,861
| New | +$188K |
|
2865
Matrix Service
MTRX
$347M
| $163K | ﹤0.01% |
+30,256
| New | +$210K |
|
|
SEI
2866
Solaris Energy Infrastructure
SEI
$3.31B
| $163K | ﹤0.01% |
19,038
+5,312
| +39% | +$51.2K |
|
2867
Vivid Seats
SEAT
$77M
| $162K | ﹤0.01% |
1,061
-3,136
| -75% | -$490K |
|
2868
Ecopetrol
EC
$32.9B
| $161K | ﹤0.01% |
15,227
-69,590
| -82% | -$756K |
|
2869
Janux Therapeutics
JANX
$935M
| $159K | ﹤0.01% |
+13,167
| New | +$219K |
|
|
ITI
2870
DELISTED
Iteris, Inc.
ITI
| $159K | ﹤0.01% |
+33,848
| New | +$142K |
|
2871
Cullinan Oncology
CGEM
$1.05B
| $159K | ﹤0.01% |
+15,502
| New | +$171K |
|
2872
Accuray
ARAY
$28.4M
| $158K | ﹤0.01% |
+53,170
| New | +$145K |
|
2873
Coursera
COUR
$1.54B
| $157K | ﹤0.01% |
13,668
-20,403
| -60% | -$264K |
|
|
AHRT
2874
AH Realty Trust
AHRT
$534M
| $156K | ﹤0.01% |
+13,233
| New | +$163K |
|
|
AMAM
2875
DELISTED
Ambrx Biopharma Inc
AMAM
| $156K | ﹤0.01% |
+17,511
| New | +$88K |
|
Similar funds
Squarepoint's Q1 2023 Portfolio in Review
As of Q1 2023, Squarepoint held 4,039 positions worth $24.5B, down 3% from $25.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Squarepoint deployed $1.16B of net new capital in Q1 2023, opening 907 new positions and adding to 1,143 existing holdings. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,782,957 shares worth $210M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was State Street Materials Select Sector SPDR ETF, an estimated $233M trimmed.
- Squarepoint's largest Q1 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,782,957 shares worth $210M.
- Squarepoint added most to CVS Health in Q1 2023, an estimated $132M increase.
- Squarepoint's biggest Q1 2023 reduction was State Street Materials Select Sector SPDR ETF, cutting an estimated $233M.
- Squarepoint fully exited Mondelez International in Q1 2023, selling an estimated $95.9M.
- Squarepoint's ten largest holdings make up 15% of its $24.5B portfolio in Q1 2023.
- Squarepoint opened 907 new positions and closed 874 in Q1 2023.
- Squarepoint's portfolio value fell 3% quarter-over-quarter to $24.5B.
Based on Squarepoint's 13F filing for Q1 2023, filed 15 May 2023.